share_log

LS Investment Advisors LLC Makes New $27,000 Investment in Cardinal Health, Inc. (NYSE:CAH)

LS Investment Advisors LLC Makes New $27,000 Investment in Cardinal Health, Inc. (NYSE:CAH)

LS Investment Advisors LLC向Cardinal Health,Inc.(紐約證券交易所代碼:CAH)新投資2.7萬美元
Financial News Live ·  2022/10/06 10:11

LS Investment Advisors LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH – Get Rating) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 511 shares of the company's stock, valued at approximately $27,000.

根據LS Investment Advisors LLC向美國證券交易委員會(Securities And Exchange Commission)的最新披露,該公司在第二季度購買了Cardinal Health,Inc.(紐約證券交易所代碼:CAH-GET評級)的新頭寸。該公司購買了511股該公司股票,價值約2.7萬美元。

Other hedge funds also recently modified their holdings of the company. Manchester Capital Management LLC boosted its position in shares of Cardinal Health by 60.4% in the first quarter. Manchester Capital Management LLC now owns 494 shares of the company's stock worth $28,000 after acquiring an additional 186 shares during the last quarter. AdvisorNet Financial Inc boosted its position in shares of Cardinal Health by 23.3% in the first quarter. AdvisorNet Financial Inc now owns 1,028 shares of the company's stock worth $58,000 after acquiring an additional 194 shares during the last quarter. Wesbanco Bank Inc. boosted its position in shares of Cardinal Health by 3.4% in the second quarter. Wesbanco Bank Inc. now owns 5,905 shares of the company's stock worth $308,000 after acquiring an additional 196 shares during the last quarter. KB Financial Partners LLC boosted its position in shares of Cardinal Health by 2.5% in the first quarter. KB Financial Partners LLC now owns 8,267 shares of the company's stock worth $469,000 after acquiring an additional 199 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. raised its holdings in Cardinal Health by 23.8% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 1,041 shares of the company's stock valued at $59,000 after buying an additional 200 shares during the period. 85.07% of the stock is owned by institutional investors and hedge funds.

其他對衝基金最近也調整了對該公司的持股。曼徹斯特資本管理公司在第一季度將其在紅衣主教健康公司股票的頭寸增加了60.4%。曼徹斯特資本管理公司在上個季度增持了186股後,現在持有494股該公司股票,價值2.8萬美元。AdvisorNet Financial Inc.在第一季度將其在Cardinal Health的股票頭寸增加了23.3%。AdvisorNet Financial Inc現在擁有1,028股該公司股票,價值58,000美元,此前該公司在上個季度又收購了194股。WesBanco Bank Inc.在第二季度將其在Cardinal Health的股票頭寸增加了3.4%。WesBanco Bank Inc.在上個季度增持了196股後,目前持有5,905股該公司股票,價值30.8萬美元。KB Financial Partners LLC在第一季度將其在Cardinal Health的股票頭寸增加了2.5%。KB Financial Partners LLC現在擁有該公司8,267股股票,價值46.9萬美元,在上個季度增持了199股。最後,本傑明·F·愛德華茲公司(Benjamin F.Edwards&Company Inc.)在第一季度將其在Cardinal Health的持股比例提高了23.8%。本傑明·F·愛德華茲公司(Benjamin F.Edwards&Company Inc.)在此期間又購買了200股,現在擁有1,041股該公司股票,價值5.9萬美元。85.07%的股票由機構投資者和對衝基金持有。

Get
到達
Cardinal Health
康德樂
alerts:
警報:

Analyst Ratings Changes

分析師評級發生變化

Several research analysts recently commented on CAH shares. Credit Suisse Group raised their price target on shares of Cardinal Health from $56.00 to $64.00 and gave the company a "neutral" rating in a report on Friday, August 12th. Barclays lifted their price objective on shares of Cardinal Health to $67.00 in a research note on Monday, August 15th. StockNews.com upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Friday, August 12th. Evercore ISI lifted their price objective on shares of Cardinal Health to $75.00 in a research note on Monday, August 15th. Finally, Mizuho lifted their price objective on shares of Cardinal Health from $58.00 to $66.00 in a research note on Friday, August 12th. Seven analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $70.20.

幾位研究分析師最近對CAH的股票發表了評論。瑞士信貸集團在8月12日星期五的一份報告中將紅衣主教健康公司的股票目標價從56.00美元上調至64.00美元,並給予該公司“中性”評級。巴克萊在8月15日星期一的一份研究報告中將紅衣主教健康公司的股票目標價上調至67.00美元。在8月12日星期五的一份研究報告中,StockNews.com將紅衣主教健康公司的股票評級從“買入”上調至“強力買入”。Evercore ISI在8月15日星期一的一份研究報告中將紅衣主教健康公司的股票目標價上調至75.00美元。最後,瑞穗在8月12日星期五的一份研究報告中將紅衣主教健康的股票目標價從58.00美元上調至66.00美元。七位分析師對該股的評級為持有,三位分析師給出了買入評級,一位分析師給出了強烈的買入評級。根據MarketBeat,該股平均評級為持有,共識目標價為70.20美元。

Cardinal Health Trading Down 0.6 %

紅衣主教健康指數下跌0.6%

Shares of NYSE:CAH opened at $69.39 on Thursday. The company has a fifty day simple moving average of $67.01 and a 200 day simple moving average of $60.14. The firm has a market cap of $18.18 billion, a PE ratio of 10.42, a price-to-earnings-growth ratio of 1.25 and a beta of 0.76. Cardinal Health, Inc. has a 12-month low of $45.85 and a 12-month high of $72.28.
紐約證交所:CAH股價週四開盤報69.39美元。該公司的50日簡單移動均線切入位為67.01美元,200日簡單移動均線切入位為60.14美元。該公司市值為181.8億美元,市盈率為10.42,市盈率為1.25,貝塔係數為0.76。Cardinal Health,Inc.的股價為45.85美元,為12個月低點,12個月高位為72.28美元。

Cardinal Health (NYSE:CAH – Get Rating) last issued its quarterly earnings results on Thursday, August 11th. The company reported $1.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.17 by ($0.12). The company had revenue of $47.10 billion during the quarter, compared to the consensus estimate of $44.82 billion. Cardinal Health had a positive return on equity of 568.57% and a negative net margin of 0.51%. The firm's quarterly revenue was up 10.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.77 EPS. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 5.23 EPS for the current fiscal year.

Cardinal Health(紐約證券交易所代碼:CAH-GET評級)最近一次發佈季度收益報告是在8月11日星期四。該公司公佈本季度每股收益(EPS)為1.05美元,低於分析師普遍預期的1.17美元(0.12美元)。該公司本季度營收為471億美元,而市場普遍預期為448.2億美元。紅衣主教健康集團的股本回報率為正568.57%,淨利潤率為負0.51%。該公司季度營收同比增長10.6%。去年同一季度,該公司公佈的每股收益為0.77美元。作為一個整體,股票研究分析師預測,Cardinal Health,Inc.本財年每股收益將達到5.23美元。

Cardinal Health Announces Dividend

紅衣主教健康公司宣佈分紅

The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, October 15th. Shareholders of record on Monday, October 3rd will be issued a $0.4957 dividend. This represents a $1.98 dividend on an annualized basis and a yield of 2.86%. The ex-dividend date of this dividend is Friday, September 30th. Cardinal Health's dividend payout ratio is presently 29.73%.

該公司最近還披露了季度股息,將於10月15日星期六支付。10月3日星期一登記在冊的股東將獲得0.4957美元的股息。這意味着年化股息為1.98美元,收益率為2.86%。本次股息除息日為9月30日(星期五)。紅衣主教健康公司的股息支付率目前為29.73%。

Cardinal Health Profile

紅衣主教健康概況

(Get Rating)

(獲取評級)

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Cardinal Health,Inc.在美國、加拿大、歐洲、亞洲和國際上作為一家綜合保健服務和產品公司運營。它為醫院、醫療保健系統、藥房、門診手術中心、臨牀實驗室、醫生辦公室和家中的患者提供定製的解決方案。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Cardinal Health (CAH)
  • 3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
  • Don't Forget About These Cheap, Fundamentally Strong Tech Stocks
  • Bellwether RPM International Pops On Results
  • Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
  • Hot Potato: Lamb Weston Stock Confirms a Top
  • 免費獲取StockNews.com關於基本健康(CAH)的研究報告
  • 隨着治療競賽升温,3只阿爾茨海默病股票將被買入
  • 不要忘記這些廉價的、從根本上強勁的科技股
  • 領頭羊RPM國際流行業績
  • Rivian打掉了包袱,但仍有很多事情要做
  • 辣土豆:韋斯頓羊肉庫存漲幅居前

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Get Rating).

想看看其他對衝基金持有什麼CAH嗎?訪問HoldingsChannel.com獲取紅衣主教健康公司(紐約證券交易所代碼:CAH-GET評級)的最新13F文件和內幕交易。

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.

接受《紅衣主教健康日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cardinal Health和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論